Main Content
Article
Communicable Disease Reporting
Communicable Disease Reporting Rule
- 2015 Communicable Disease Reporting Rule
- Indiana State Health Commissioner Kris Box, MD, FACOG Reporting Rule for COVID-19
To report a case of a reportable disease please complete this form and fax to 317-234-2812 or call the ISDH Epidemiology Resource Center at 317-233-7125 (8:15 am- 4:45 pm) or 317-233-1325 (after hours, weekends, holidays).
Acquired Immunodeficiency Syndrome (AIDS) | Cysticercosis (Taenia solium) | Hepatitis, viral, Type Delta | *Mumps | Staphylococcus aureus, vancomycin resistance level of MIC ≥ 8 µg/mL or severe Staphylococcus aureus in a previously healthy person |
*Animal Bites | ! Dengue | ! Hepatitis, viral, Type E | *Novel influenza A | Streptococcus pneumoniae, invasive disease and antimicrobial susceptibility testing |
Anaplasmosis (Anaplasma species) | ! Diphtheria (Corynebacterium diphtheriae) | Hepatitis, viral, unspecified | *Pertussis (Bordetella pertussis) | Streptococcus, Group A, invasive disease (Streptococcus pyogenes) |
! Anthrax (Bacillus anthracis) | ! Eastern equine encephalitis (EEE) | Histoplasmosis (Histoplasma capsulatum) | ! Plague (Yersinia pestis) | Syphilis (Treponema pallidum) |
! Arboviral (Eastern Equine, St. Louis, La Crosse, West Nile, California, Western Equine, Powassan, Japanese) | Ehrlichiosis (Ehrlichia species) | HIV infection/disease (The following conditions related to HIV are laboratory reportable) Cryptococcus neoformans Kaposi’s sarcoma (biopsies) Pneumocystis carinii |
! Poliomyelitis | Tetanus (Clostridium tetani) |
Babesiosis (Babesia species) |
! Escherichia coli infection (Shiga toxin‐ producing E. coli (STEC)) including, but not limited to: E. coli O157; E. coli O157:H7; Shiga toxin detected; or Non‐O157 E. coli |
! HIV infection/disease, pregnant woman or perinatally exposed infant | ! Powassan virus | Toxic shock syndrome (streptococcal or staphylococcal) |
! Botulism (Clostridium botulinum) | Giardiasis (Giardia species) | Influenza‐associated death (all ages) | Psittacosis (Chlamydia psittaci) | Trichinosis (Trichinella spiralis) |
! Brucellosis (Brucella species) | Gonorrhea (Neisseria gonorrheae) | ! Japanese encephalitis | ! Q Fever (Coxiella burnetti) | *Tuberculosis, cases, suspects, and latent infection (Mycobacterium tuberculosis) For latent infection, a positive screening test, negative or normal chest x‐ray, no evidence of extra‐pulmonary disease, and provider diagnosis are necessary. Report latent infection within five (5) business days. |
Campylobacteriosis (Campylobacter species) | Granuloma inguinale (Calymmatobacterium granulomatis) | ! La Crosse encephalitis (California serogroup viruses) | ! Rabies in humans or animals, confirmed and suspect animal with human exposure | ! Tularemia (Francisella tularensis) |
Carbapenemase‐producing Carbapenem‐ resistant Enterobacteriaceae (CP‐CRE) | *Haemophilus influenzae, invasive diseas | Legionellosis (Legionella species) | Rabies, postexposure treatment | ! Typhoid and paratyphoid fever, cases and carriers (Salmonella Typhi or Paratyphi) |
Chancroid (Haemophilus ducreyi) | Hansen’s disease (leprosy) (Mycobacterium leprae) |
Leptospirosis (Leptospira species | Rocky Mountain spotted fever (Rickettsia species) | Typhus, endemic (flea‐borne) |
! Chikungunya virus | ! Hantavirus pulmonary syndrome | Listeriosis (Listeria monocytogenes, invasive) |
! Rubella (German Measles) | Varicella (chicken pox) |
Chlamydia trachomatis, genital infection | ! Hemolytic uremic syndrome, postdiarrheal | Lyme disease (Borrelia burgdorferi) | ! Rubella congenital syndrome | Vibriosis (Vibrio species) |
! Cholera (Vibrio cholerae) | ! Hepatitis, viral, Type A | Lymphogranuloma venereum | Salmonellosis, non‐typhoidal (Salmonella species) | ! West Nile Virus (WNV) |
Coccidioidomycosis |
Hepatitis, viral, Type B | Malaria (Plasmodium species) | ! Shigellosis (Shigella species) | ! Western equine encephalitis (WEE) |
*COVID-19, cases, deaths
|
! Hepatitis, viral, Type B, pregnant woman (acute and chronic) or perinatally exposed infant | ! Measles (Rubeola) | ! Smallpox (Variola infection) Adverse events or complications due to smallpox vaccination (vaccinia virus infection) or secondary transmission to others after vaccination. | ! Yellow fever |
Cryptosporidiosis (Cryptosporidium species) |
Hepatitis, viral, Type C (acute), within five (5) business days | ! Meningococcal disease (Neisseria meningitidis, invasive) | ! St. Louis encephalitis (SLE) | Yersiniosis (Yersinia species) |
Cyclosporiasis (Cyclospora cayetanensis) |
Effective immediately (2/6/2018) cases of chlamydia, gonorrhea, and syphilis should be reported using this form. Phone and fax numbers for your county can be found on the ISDH STD Prevention webpage under the “STD Morbidity Reporting in Indiana” heading.
Resources
- Rule Change Notification Letter
- Changes to Communicable Disease Rule
- Confidential Report of Communicable Diseases Form (Updated 2/2/2018; please review the listed conditions carefully, as some have been removed)
- Indiana Confidential Sexually Transmitted Disease (STD) Reporting Form (Updated 2/6/2018)
- Lab
- 2015 Reportable Disease List (Edited 9/11/2020)
- Communicable Disease Reporting Presentation Slides
- HIPAA and Public Health Letter
Page last updated: September 21, 2020
Page last reviewed: August 1, 2016